ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135925 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135925; 2) Community: the network communities that were significantly associated with the response to NSC 135925; 3) Molecule: the relationships between components within communities and NSC 135925; 4) MDR: the compounds that were significantly associated with the NSC 135925.

NSC Compound Enrichment Correlation
NSC 615538 ANTINEOPLASTIC-615538 0.0105607789694647 0.2813579
NSC 649811 2H-1-Benzopyran-3-acetamide, N-(3-chloro-1,4-dioxo- 2-naphthyl)-4-hydroxy-.beta.,2-dioxo- 0.0105607789694647 0.22066916
NSC 658450 2-Acetamido-6-methyl-8-hydroxy-1,4-naphthaquinone 0.0105607789694647 0.30941242
NSC 685860 Null 0.0105607789694647 -0.18031479
NSC 697747 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(3-methoxyphenyl)- 0.0105607789694647 0.24886075
NSC 718579 Null 0.0105607789694647 0.25469625
NSC 748909 Chonemorphine 0.0105607789694647 0.49870297
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.0119221520283057 0.31059474
NSC 175493 Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- 0.0119221520283057 0.30767842
NSC 616960 2[5H]-Furanone, 5-[(.beta.-D-glucopyranosyloxy)methyl]-,(S)- (9CI) 0.0119221520283057 0.52148898
Total:44  Current:8    [First] [Prev] [Next] [Last]